Study guide

Endophthalmitis diagnosis and treatment

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Endophthalmitis diagnosis and treatment

Key Takeaways Explain This Topic AI

Suspected endophthalmitis is an urgent clinical diagnosis requiring appropriate sampling and intravitreal treatment.

EVS evidence concerns a defined postoperative population and cannot be applied unchanged to every infection source.

Endogenous, traumatic and bleb-related disease require their own organism, systemic and surgical considerations.

Last updated: October 2026

Acute Post-Cataract Endophthalmitis

Acute post-cataract endophthalmitis represents a catastrophic purulent intraocular infection involving the vitreous and anterior chambers. The reported incidence across modern European phacoemulsification cohorts ranges between 0.03% and 0.08% (approximately 1 in 1,200 to 1 in 3,000 surgeries). Routine intracameral cefuroxime (1.0 mg in 0.1 mL) prophylaxis at the conclusion of surgery has decreased the incidence five-fold (as demonstrated in the landmark ESCRS multicenter study).

Clinical Presentation and Timing

Timeline: Characteristically presents between postoperative days 3 and 7 (median onset: day 5). Presentations after 6 weeks are classified as chronic pseudophakic endophthalmitis (typically caused by low-virulence organisms such as Cutibacterium acnes , Corynebacterium , or fungi).

Primary Source: In > 80 % >80\% > 80% of cases, molecular typing confirms that the infecting organism originates from the patient's own ocular surface flora (eyelashes, eyelid margin, and conjunctival sac) entering the eye during surgery or through an unsealed clear corneal wound in the early postoperative period.

Symptoms:

Rapid, progressive deterioration of visual acuity out of proportion to normal postoperative recovery;

Severe, deep, throbbing ocular and periorbital pain ( important exam caveat: pain is absent in up to 25% of patients , meaning absence of pain never excludes endophthalmitis);

Marked photophobia, eyelid oedema, and red eye.

Physical Signs:

  • Eyelid oedema and profound conjunctival/ciliary injection;
  • Corneal epithelial and stromal oedema with Descemet folds;
  • Dense anterior chamber cells, fibrin membranes across the pupil/IOL, and a progressive hypopyon ;

Dense vitritis obscuring retinal vessel architecture and complete loss of the red reflex on distant direct ophthalmoscopy.

Microbiology of Acute Postoperative Endophthalmitis

Pathogen Group Specific Microorganisms Frequency (%) Virulence & Clinical Characteristics

Coagulase-Negative Staphylococci (CoNS) Staphylococcus epidermidis (predominant), S. lugdunensis ~70% Biofilm producers; low-to-moderate virulence; indolent onset; best visual prognosis ( > 80 % >80\% > 80% achieve ≥ 20 / 100 \ge 20/100 ≥ 20/100 ).

Staphylococcus aureus Methicillin-sensitive (MSSA) and Methicillin-resistant (MRSA) 10–15% High virulence; potent exotoxins; aggressive inflammatory destruction; intermediate visual outcomes.

Streptococcus species Streptococcus pneumoniae , S. viridans , S. pyogenes ~10% Highly virulent; rapid enzymatic tissue destruction; dense fibrin coagulum; poor visual recovery.

Gram-Negative Bacilli Pseudomonas aeruginosa , Enterobacter , Klebsiella , Proteus 5–10% Devastating necrotising intraocular destruction; rapid corneal melting; worst visual prognosis.

The Landmark Endophthalmitis Vitrectomy Study (EVS)

EVS studied acute postoperative bacterial endophthalmitis after cataract extraction or secondary-IOL implantation in the 1990s. Immediate vitrectomy benefited eyes with light-perception-only acuity; better-vision eyes had similar outcomes with initial tap/inject and vitrectomy. This is evidence for that population and technology, not a rule that hand-motions acuity forbids modern vitrectomy.

The systemic antibiotics tested did not improve outcomes; that does not establish that every systemic antimicrobial is useless in every endophthalmitis type. Endogenous, fungal, traumatic and bleb-related infections differ and can require systemic therapy, source control or different surgery. Consider pathogen, progression, retinal visibility, lens/capsule infection, pressure and response. Do not delay effective intravitreal treatment awaiting culture or a surgery slot.

Sampling and Intravitreal Treatment

Obtain vitreous and sometimes aqueous samples for microscopy and culture, with molecular tests when indicated. Samples must reach the appropriate laboratory promptly. Coordinate with the vitreoretinal surgeon and microbiologist and document prior antibiotics. A negative culture does not exclude infection.

Common empiric adult intravitreal coverage is vancomycin 1 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL. Pharmacy preparation, final concentration, syringe labelling and route checks are essential. Give separate syringes according to validated local protocol; a bedside dilution recipe is not adequate quality assurance. Allergy and local susceptibility may require an alternative such as amikacin, whose retinal toxicity risk needs particular care. Intravitreal corticosteroid adjunct evidence is uncertain and does not justify delaying antibiotics.

Follow closely for clinical response, pressure, retinal status and the need for repeat treatment or vitrectomy. Repeated doses are a clinical decision, not dependent only on a positive culture. Inform the patient about prognosis, treatment urgency and possible additional surgery.

Bleb-Associated Endophthalmitis

Bleb-associated endophthalmitis develops as a late, vision-threatening complication following glaucoma filtration surgery (trabeculectomy or express shunt). It can arise months, years, or decades postoperatively (mean onset: 2 to 5 years).

Pathophysiological Risk Factors

Thin, avascular, transconjunctival, cystic filtration blebs resulting from intraoperative antifibrotic antimetabolites ( Mitomycin C [MMC] or 5-Fluorouracil [5-FU] );

  • Inferiorly situated trabeculectomy blebs (bathed in contaminated tear film pools);
  • Late bleb leaks (positive Seidel test);

Chronic blepharitis and recurrent conjunctivitis.

Clinical Staging

Blebitis : A purulent inflamed bleb without established vitreous involvement requires urgent intensive antimicrobial management and close review according to local protocol. Check for a leak and posterior extension; progression to endophthalmitis needs intravitreal treatment and surgical assessment.

Stage 2 (Bleb-Associated Endophthalmitis): Microorganisms breach the thin conjunctival wall and enter the anterior chamber and vitreous cavity. Presents with severe ocular pain, profound visual loss, dense anterior chamber fibrin, hypopyon, and marked vitritis.

Microbiology: Aggressive virulent upper respiratory tract and oral commensals: Streptococcus pneumoniae , Haemophilus influenzae , Moraxella catarrhalis , and Pseudomonas aeruginosa . Visual prognosis is significantly poorer than acute post-cataract endophthalmitis, frequently demanding urgent vitrectomy.

Post-Traumatic Endophthalmitis

Post-traumatic endophthalmitis develops in 3% to 10% of penetrating open-globe injuries, escalating to > 15 % >15\% > 15% in the presence of a retained intraocular foreign body (IOFB) .

  • Key Risk Factors
  • Delayed primary surgical wound closure ( > 24 hours >24\text{ hours} > 24 hours post-injury);
  • Open-globe injury occurring in a rural, farmyard, or soil-contaminated environment ;
  • Retained intraocular foreign body;

Traumatic rupture of the crystalline lens capsule.

Microbiology and The Bacillus cereus Emergency

Bacillus cereus : A spore-forming, Gram-positive rod responsible for up to 25% to 45% of farmyard/soil-contaminated penetrating trauma. It produces powerful necrotising exotoxins (hemolysin, cereolysin) causing fulminant panophthalmitis within 12 to 24 hours of injury . Signs include prostrating pain, high fever, systemic leukocytosis, rapid corneal chemosis and melting, a characteristic ring corneal infiltrate , and gas bubbles in the anterior chamber. Over 80% of affected eyes lose all light perception or require enucleation/evisceration within 24 to 48 hours without immediate intervention.

Other Pathogens: Coagulase-negative staphylococci, polymicrobial infections, and filamentous fungi ( Aspergillus , Fusarium ).

Therapeutic Management: Immediate primary open-globe repair and IOFB extraction, combined with intravitreal vancomycin ( 1.0 mg 1.0\text{ mg} 1.0 mg ) and ceftazidime ( 2.25 mg 2.25\text{ mg} 2.25 mg ). Unlike post-cataract endophthalmitis, systemic intravenous antibiotics ARE indicated (IV vancomycin 1 g 1\text{ g} 1 g q12h + IV ceftazidime 2 g 2\text{ g} 2 g q8h or ciprofloxacin) to prevent orbital cellulitis and extraocular extension.

Endogenous Endophthalmitis

Endogenous endophthalmitis results from the hematogenous dissemination of circulating microorganisms across the blood-retinal or blood-aqueous barrier, establishing metastatic foci within the vascular choroid or retina that subsequently erupt into the vitreous.

  • Predisposing Risk Factors
  • Indwelling central venous lines and total parenteral nutrition (TPN);
  • Intravenous drug abuse (IVDU);
  • Systemic immunosuppression, chemotherapy, haematological malignancies, and diabetes mellitus;

Remote septic foci: infective endocarditis, urinary tract infections, pyogenic liver abscesses, or recent major abdominal/pelvic surgery.

Microbiology and Clinical Entities

Fungal endogenous endophthalmitis:

Candida albicans (most common): Typically occurs in patients with indwelling vascular catheters, TPN, or IVDU. Characterized by focal, fluffy, creamy-white chorioretinal infiltrates at the posterior pole, breaking through the internal limiting membrane to form characteristic spherical vitreous colonies resembling a "string of pearls" or "cotton balls" .

Aspergillus species: High mortality; observed in organ transplant recipients and profound neutropenia. Produces aggressive, elevated macular subretinal abscesses and extensive vascular thrombosis.

Management: High-dose systemic antifungals (IV Voriconazole 400 mg 400\text{ mg} 400 mg load then 200 mg 200\text{ mg} 200 mg twice daily, or oral Fluconazole 400 – 800 mg/day 400\text{--}800\text{ mg/day} 400 – 800 mg/day ) PLUS Intravitreal Amphotericin B ( 5 – 10 μ g in 0.1 mL 5\text{--}10\,\mu\text{g in }0.1\text{ mL} 5 – 10 μ g in 0.1 mL ) or Intravitreal Voriconazole ( 100 μ g in 0.1 mL 100\,\mu\text{g in }0.1\text{ mL} 100 μ g in 0.1 mL ) , combined with early therapeutic pars plana vitrectomy for vitreal involvement.

Bacterial Endogenous Endophthalmitis (40–50% of cases):

Klebsiella pneumoniae : Highly endemic across East Asia (Taiwan, Korea, Singapore); strongly linked to cryptogenic pyogenic liver abscesses in diabetic patients carrying the hypervirulent K1/K2 capsular serotype. Causes explosive, catastrophic panophthalmitis with subretinal abscesses and high bilateral incidence (up to 25%).

Staphylococcus aureus & Streptococcus pneumoniae : Associated with infective tricuspid endocarditis (in IVDU) and pneumococcal meningitis/pneumonia.

Management: Comprehensive systemic sepsis workup (blood cultures × 3 \times 3 × 3 , echocardiography, abdominal ultrasound/CT, urine culture), high-dose intravenous systemic antimicrobial therapy directed at the primary source, accompanied by immediate intravitreal vancomycin + ceftazidime and early vitrectomy.